Status:
RECRUITING
Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
Lead Sponsor:
University of California, Los Angeles
Conditions:
Frailty
Sarcopenia
Eligibility:
All Genders
18+ years
Brief Summary
Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can ide...
Detailed Description
Frailty is the decline in physical and cognitive reserves leading to increased vulnerability to stressors such as surgery or disease states. Frailty is not a disease, but a syndrome with a distinct fr...
Eligibility Criteria
Inclusion
- Adult patients admitted to the Surgical, Cardiothoracic or Neuro ICU
- ICU stay longer than 24 hours
Exclusion
- Patients with muscular or mitochondrial diseases affecting muscle quality or mass
- Preexisting paralysis
- Absence of lower limbs
- Ongoing discussions about goals of care
- Transfers from a skilled nursing facility
- Children under the age of 18
Key Trial Info
Start Date :
September 22 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04717869
Start Date
September 22 2023
End Date
July 1 2026
Last Update
November 25 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine
Los Angeles, California, United States, 90095